Scientists hunt for clues in blood cancer patients

NCT ID NCT04546945

Recruiting now Knowledge-focused Sponsor: Asmaa Hassan mohamed Abdel Mawjoud Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how a specific protein called CD56 appears in different types of blood cancers. Researchers will measure CD56 levels in 38 newly diagnosed patients to see if its presence is linked to how the disease progresses. The goal is to gather knowledge that may help doctors better understand these cancers in the future.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Assiut University
COMPLETED

Asyut, Egypt
Assiut university
RECRUITING

Asyut, Egypt

Contact

Conditions

Explore the condition pages connected to this study.

HEMATOLOGIC MALIGNANCIES